Strategic M&A: Sanofi Buys Principia Biopharma For $3.7bn

Removes Sanofi Royalty Payments on Brain-Penetrant SAR442168

 
• By Sten Stovall
Merger
Sanofi says US biotech buy ‘fully aligned with our R&D priorities.’ • Source: Shutterstock

More from Deals

More from Business